2004
DOI: 10.1038/sj.gt.3302415
|View full text |Cite
|
Sign up to set email alerts
|

Vector integration: Location, location, location

Abstract: A new analysis of vector integration has shown how integration site varies among three different groups of retroviruses 1

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2007
2007
2014
2014

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 23 publications
0
2
0
Order By: Relevance
“…One might, however, argue that, since all the retroviral sequences mentioned so far are GC-rich [31], integration into GC-rich isochores could depend upon the requirement for a compositional match between the retroviral sequence and the isochores of the host genome without being related to chromatin “openness”. Integration into GC-rich isochores was also found, however, for exogenous Mouse Mammary Tumor Virus (MMTV; [32]) and Human Immunodeficiency Virus (HIV-I; [6], [33][36]) which are GC-poor. This obviously favors the idea of an integration into open chromatin structures.…”
Section: Discussionmentioning
confidence: 99%
“…One might, however, argue that, since all the retroviral sequences mentioned so far are GC-rich [31], integration into GC-rich isochores could depend upon the requirement for a compositional match between the retroviral sequence and the isochores of the host genome without being related to chromatin “openness”. Integration into GC-rich isochores was also found, however, for exogenous Mouse Mammary Tumor Virus (MMTV; [32]) and Human Immunodeficiency Virus (HIV-I; [6], [33][36]) which are GC-poor. This obviously favors the idea of an integration into open chromatin structures.…”
Section: Discussionmentioning
confidence: 99%
“…The short half-life ( t 1/2 ∼1.5 min) of siRNA in blood and need for intracellular delivery are challenges for translation to the clinic. A variety of methods have been developed to deliver siRNA, including direct intravenous injection of “naked” or chemically stabilized siRNA, , packaging of siRNA into DNA plasmid vectors, , transposon vectors (transgenic plasmids), plasmid-infected viruses, virosomes (reconstituted viral envelopes), lentiviral vectors, , and liposomes . We have previously demonstrated that pH-responsive liposomes are advantageous for delivering siRNA, because they not only improve pharmacokinetics but also provide a stable shield from enzyme degradation …”
Section: Introductionmentioning
confidence: 99%